DEBASISH TRIPATHY to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Antineoplastic Agents, Immunological.
Connection Strength
0.126
-
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer. 2021 03; 9(3).
Score: 0.096
-
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clin Cancer Res. 2024 Jun 03; 30(11):2424-2432.
Score: 0.030